EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PPARγ-SMAD6 axis-mediated inhibition of osteogenic differentiation is involved in BPS-induced osteoporosis

Zhenkun Weng, Xiu Chen, Jian Jiao, Zuqiang Fu, Qian Liu, Jin Xu, Hongchao Zhang, Qingzhi Hou, Dongmei Wang, Jiong Li, Shourui Wang, Zhen Zhang und 4 weitere

Environment International · 2025-04 · 198 · 109442

DOI: 10.1016/j.envint.2025.109442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environment International, 2025-04. Verfasst von Zhenkun Weng und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiang…. Hauptthemen laut MEDLINE: PPAR gamma, Osteoporosis, Osteogenesis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Research of Jiangsu Higher Education Institutions of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bisphenol S (BPS) is extensively utilized in personal care products, foods, and paper products, raising growing concerns about its potential environmental hazards. However, few studies have reported the effects of BPS exposure on bone homeostasis. In this study, using data from the National Health and Nutrition Examination Survey, we found a negative correlation between urinary BPS and bone mineral density (BMD). To further investigate the underlying mechanisms, C57BL/6 mice were exposed to a human-equivalent dose of BPS for 6 months. Micro-CT analysis demonstrated reduced femoral BMD in the mice, indicating that osteoporosis was caused by chronic exposure. RNA-seq analysis showed that BPS activated PPARγ in human primary mesenchymal stem cells (MSCs). Additionally, 3D molecular docking confirmed a direct interaction between BPS and PPARγ. Bioinformatics analysis identified SMAD6 as a downstream target of PPARγ. Mechanistically, the BPS-PPARγ interaction activated PPARγ, promoting SMAD6 transcription, which inhibited the osteogenic differentiation of MSCs. High-throughput virtual screening further revealed that olodanrigan effectively blocked the BPS-PPARγ interaction, and in vitro assays revealed that olodanrigan blocked the inhibition of osteogenic differentiation of MSCs induced by BPS. Additionally, olodanrigan supplementation inhibited PPARγ levels, thereby reversing BPS-induced osteoporosis. In summary, this study elucidates the role of the PPARγ-SMAD6 axis in mediating BPS-induced osteoporosis and highlights olodanrigan as a promising therapeutic intervention, offering new insights into the health risks posed by BPS and potential targets for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR gammaOsteoporosisOsteogenesisAnimalsMiceHumansMice, Inbred C57BLCell DifferentiationMesenchymal Stem CellsBone DensityMaleFemaleMolecular Docking Simulation

Stichwörter der Autor:innen

BPSOsteogenic differentiationOsteoporosisPPARγ

Substanzen

PPAR gamma

Autor:innen und Institutionen

  • State Key Laboratory of Reproductive Medicine and Offspring Health, School of Public Health, Nanjing Medical University, Nanjing 211166, China; Jiangsu Environmental Health Risk Assessment Engineering Research Center, K…
  • Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, Nanjing 211166, China.
  • School of Public Health and Management, Shandong First Medical University, Jinan, Shandong 250117, China.
  • Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou 213004, China.

Förderung

  • National Key Research and Development Program of China
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Jiangsu Province Natural Science Foundation

Zitieren

APA

Weng, Z., Chen, X., Jiao, J., Fu, Z., Liu, Q., Xu, J., Zhang, H., Hou, Q., Wang, D., Li, J., Wang, S., Zhang, Z., Chen, Y., Meng, S., Jiang, Z., & Gu, A. (2025). PPARγ-SMAD6 axis-mediated inhibition of osteogenic differentiation is involved in BPS-induced osteoporosis. Environment International, 198, 109442. https://doi.org/10.1016/j.envint.2025.109442

Vancouver

Weng Z, Chen X, Jiao J, Fu Z, Liu Q, Xu J, et al. PPARγ-SMAD6 axis-mediated inhibition of osteogenic differentiation is involved in BPS-induced osteoporosis. Environment International. 2025;198:109442. doi:10.1016/j.envint.2025.109442

BibTeX
@article{Weng2025,
  author = {Weng, Zhenkun and Chen, Xiu and Jiao, Jian and Fu, Zuqiang and Liu, Qian and Xu, Jin and Zhang, Hongchao and Hou, Qingzhi and Wang, Dongmei and Li, Jiong and Wang, Shourui and Zhang, Zhen and Chen, Yanlong and Meng, Sining and Jiang, Zhaoyan and Gu, Aihua},
  title = {PPARγ-SMAD6 axis-mediated inhibition of osteogenic differentiation is involved in BPS-induced osteoporosis},
  journal = {Environment International},
  year = {2025},
  volume = {198},
  pages = {109442},
  doi = {10.1016/j.envint.2025.109442}
}
Kostenlos starten →